Global Pharmacovigilance Market Size is valued at USD 7.8 Bn in 2024 and is predicted to reach USD 15.3 Bn by the year 2034 at a 7.1% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The increasing number of people living with chronic diseases is predicted to drive the expansion of this market. Rising medication use, drug development rates, and outsourcing all contribute to a developing phar...
Report ID: 1608 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Continuous Bioprocessing Market Size was valued at USD 304.52 Mn in 2024 and is predicted to reach USD 1901.07 Mn by 2034 at a 20.2% CAGR during the forecast period for 2025-2034. Continuous bioprocessing is a technology utilized in the production of biopharmaceuticals, wherein manufacturing operations are interconnected seamlessly with minimal hold volume. Several factors contribute to the expansion of this market, including escalating demand...
Report ID: 2390 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Cell and Gene Therapy Manufacturing Quality Control (QC) Market Size is valued at USD 2.71 Bn in 2024 and is predicted to reach USD 16.32 Bn by the year 2034 at a 19.8% CAGR during the forecast period for 2025-2034. A crucial element in the production of cell and gene therapies, quality control (QC) guarantees the advanced therapeutic products' safety, potency, integrity, and efficacy prior to their administration to patients. Considering the ...
Report ID: 2395 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 179
Global Minimal Residual Disease Market Size is valued at USD 1.4 Bn in 2024 and is predicted to reach USD 4.6 Bn by the year 2034 at a 12.8% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: Precision oncology, which tailors cancer treatment to the molecular characteristics of an individual's cancer, is a key driver of the MRD market. Increasing the sensitivity of MRD detection methods contr...
Report ID: 1448 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Global Plant-Based Vaccines Market Size is valued at USD 409.5 Mn in 2024 and is predicted to reach USD 2,161.2 Mn by the year 2034 at an 18.2% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: Growing interest from both the public and private sectors has led to increased investment in plant-based vaccine research and development. This financial support is critical to advancing our technology...
Report ID: 1453 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 175
In vivo CAR T-cell Market Size is predicted to grow at a 32.9% CAGR during the forecast period for 2025-2034. In vivo CAR T-cell therapy is a promising development in cancer immunotherapy, enabling the genetic modification of a patient’s T cells within the body to target cancer cells. Unlike traditional CAR T-cell therapies, which require extracting, modifying, and reinfusing T cells in a lab, in vivo methods use viral vectors (such as l...
Report ID: 2999 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Global Transitional Care Management Services Market Size is valued at USD 269.3 Mn in 2024 and is predicted to reach USD 1305.6 Mn by the year 2034 at a 17.2% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: Demand for the post-discharge facility, an increase in illnesses, injuries, and operations, and investment from major market participants are all factors expected to fuel the market's he...
Report ID: 1500 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 185
Antimicrobial Peptides Market Size is valued at USD 248.53 Mn in 2024 and is predicted to reach USD 759.86 Mn by the year 2034 at a 11.9% CAGR during the forecast period for 2025-2034. AMPs possess the ability to eliminate microbial pathogens directly; others function indirectly by modulating host defense systems. Natural antimicrobial peptides are found in bacterial and eukaryotic defense systems. They defend against bacteria, viruses, and fu...
Report ID: 2335 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Global Direct-to-Consumer Genetic Testing Market Size is valued at USD 2.4 Billion in 2024 and is predicted to reach USD 16.2 Billion by the year 2034 at a 21.2% CAGR during the forecast period for 2025-2034. Direct access testing, also known as direct-to-consumer (DTC) testing, enables clients to order laboratory tests directly from a laboratory without necessarily involving their healthcare provider. Direct-to-consumer genetic testing ...
Report ID: 1376 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 180
Global DNases, ligases, and RNA Polymerases Market Size is valued at USD 735.5 Mn in 2024 and is predicted to reach USD 1722.1 Mn by the year 2034 at an 9.0% CAGR during the forecast period for 2025-2034. Key Industry Insights & Findings from the Report: The rise of RNA-based therapeutics, including mRNA vaccines and RNA interference (RNAi) therapies, presents opportunities for RNA polymerases in synthesizing therapeutic RNA molecules. T...
Report ID: 1439 |
Delivery: Immediate |
Published: May 2025 |
No. of Pages: 190
Pharmaceuticals